Cellquest is a French HealthTech startup located in Besançon, France, that has developed a 100% automated system for the production of autologous CAR-T cells, from whole blood to fill-and-finish. Cellquest’s technology eliminates cost and production barriers for autologous CAR-T cells, unlocking their market potential, boosting profitability, and expanding access to more patients.